Search

Angela A. Armstrong

Examiner (ID: 7226, Phone: (571)272-7598 , Office: P/2659 )

Most Active Art Unit
2659
Art Unit(s)
2659, 2641, 2741, 2654, 2626
Total Applications
1003
Issued Applications
675
Pending Applications
123
Abandoned Applications
230

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5953936 [patent_doc_number] => 20110034419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease' [patent_app_type] => utility [patent_app_number] => 12/824904 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 27134 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034419.pdf [firstpage_image] =>[orig_patent_app_number] => 12824904 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/824904
Cardioprotective Drugs and Diagnostics for Assessing Risk of Cardiovascular Disease Jun 27, 2010 Abandoned
Array ( [id] => 8186496 [patent_doc_number] => 20120115794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES' [patent_app_type] => utility [patent_app_number] => 13/378574 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11431 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115794.pdf [firstpage_image] =>[orig_patent_app_number] => 13378574 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/378574
USE OF CD44V6 IN THE TREATMENT OF OPHTHALMIC DISEASES Jun 10, 2010 Abandoned
Array ( [id] => 6608271 [patent_doc_number] => 20100323380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'METHODS FOR DIAGNOSING BLOOD VESSEL REOCCLUSION' [patent_app_type] => utility [patent_app_number] => 12/797144 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 6925 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323380.pdf [firstpage_image] =>[orig_patent_app_number] => 12797144 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/797144
METHODS FOR DIAGNOSING BLOOD VESSEL REOCCLUSION Jun 8, 2010 Abandoned
Array ( [id] => 8197001 [patent_doc_number] => 20120121579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE' [patent_app_type] => utility [patent_app_number] => 13/375504 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18597 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121579.pdf [firstpage_image] =>[orig_patent_app_number] => 13375504 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/375504
TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE Jun 1, 2010 Abandoned
Array ( [id] => 8208992 [patent_doc_number] => 20120128660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'DIAGNOSIS OF RESTENOSIS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION' [patent_app_type] => utility [patent_app_number] => 13/375924 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10433 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128660.pdf [firstpage_image] =>[orig_patent_app_number] => 13375924 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/375924
Diagnosis of restenosis in patients undergoing percutaneous coronary intervention Jun 1, 2010 Issued
Array ( [id] => 8920469 [patent_doc_number] => 08486400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling' [patent_app_type] => utility [patent_app_number] => 12/791785 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 38 [patent_no_of_words] => 50746 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12791785 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/791785
Methods of inhibiting unwanted cell proliferation using an antibody that binds to sonic hedgehog and inhibits hedgehog signaling May 31, 2010 Issued
Array ( [id] => 8549480 [patent_doc_number] => 08324362 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors' [patent_app_type] => utility [patent_app_number] => 12/788240 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 41355 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12788240 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/788240
Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors May 25, 2010 Issued
Array ( [id] => 6597306 [patent_doc_number] => 20100292172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 12/785396 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 46464 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292172.pdf [firstpage_image] =>[orig_patent_app_number] => 12785396 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/785396
Peptide-peptidase inhibitor conjugates and methods of using same May 20, 2010 Issued
Array ( [id] => 7586864 [patent_doc_number] => 20110281374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'BIOMARKER' [patent_app_type] => utility [patent_app_number] => 12/778230 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4044 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281374.pdf [firstpage_image] =>[orig_patent_app_number] => 12778230 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/778230
BIOMARKER May 11, 2010 Abandoned
Array ( [id] => 8228400 [patent_doc_number] => 20120142605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'METHODS OF TREATING PSORIASIS' [patent_app_type] => utility [patent_app_number] => 13/319004 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10995 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319004 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/319004
METHODS OF TREATING PSORIASIS May 4, 2010 Abandoned
Array ( [id] => 6186203 [patent_doc_number] => 20110124556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Insulin and IGF-1 Receptor Agonists and Antagonists' [patent_app_type] => utility [patent_app_number] => 12/763964 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 122 [patent_figures_cnt] => 122 [patent_no_of_words] => 48855 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124556.pdf [firstpage_image] =>[orig_patent_app_number] => 12763964 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/763964
Insulin and IGF-1 Receptor Agonists and Antagonists Apr 19, 2010 Abandoned
Array ( [id] => 8624874 [patent_doc_number] => 08357368 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-22 [patent_title] => 'Methods of treating pancreatic or liver cancer using hedgehog antagonists' [patent_app_type] => utility [patent_app_number] => 12/756939 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 55 [patent_no_of_words] => 60226 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12756939 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/756939
Methods of treating pancreatic or liver cancer using hedgehog antagonists Apr 7, 2010 Issued
Array ( [id] => 7754817 [patent_doc_number] => 20120027850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'Compositions and Methods for Treatment of Aortic Fibrosis' [patent_app_type] => utility [patent_app_number] => 13/262064 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3555 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027850.pdf [firstpage_image] =>[orig_patent_app_number] => 13262064 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/262064
Methods for the treatment of aortic fibrosis with VIP fragments Apr 5, 2010 Issued
Array ( [id] => 5938241 [patent_doc_number] => 20110213209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'MONITORING MYOCARDIAL INFARCTION AND ITS TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/748476 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10541 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213209.pdf [firstpage_image] =>[orig_patent_app_number] => 12748476 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/748476
Monitoring myocardial infarction and its treatment Mar 28, 2010 Issued
Array ( [id] => 6186291 [patent_doc_number] => 20110124580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/728948 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27752 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124580.pdf [firstpage_image] =>[orig_patent_app_number] => 12728948 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/728948
REGULATION OF LUNG TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO Mar 21, 2010 Abandoned
Array ( [id] => 8041427 [patent_doc_number] => 20120070451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'METHODS AND COMPOSITIONS FOR MODULATING CARDIAC CONTRACTILITY' [patent_app_type] => utility [patent_app_number] => 13/257590 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13056 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20120070451.pdf [firstpage_image] =>[orig_patent_app_number] => 13257590 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/257590
METHODS AND COMPOSITIONS FOR MODULATING CARDIAC CONTRACTILITY Mar 18, 2010 Abandoned
Array ( [id] => 9245325 [patent_doc_number] => 08609605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-17 [patent_title] => 'Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100' [patent_app_type] => utility [patent_app_number] => 13/257045 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13116 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13257045 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/257045
Immunomodulatory methods for treatment of atherosclerosis via inhibition of CD4+ T cell response to APOB100 Mar 16, 2010 Issued
Array ( [id] => 6635460 [patent_doc_number] => 20100226884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R)' [patent_app_type] => utility [patent_app_number] => 12/722645 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 30054 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226884.pdf [firstpage_image] =>[orig_patent_app_number] => 12722645 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/722645
Novel Class of Monospecific and Bispecific Humanized Antibodies that Target the Insulin-like Growth Factor Type I Receptor (IGF-1R) Mar 11, 2010 Abandoned
Array ( [id] => 6635348 [patent_doc_number] => 20100226878 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS' [patent_app_type] => utility [patent_app_number] => 12/716986 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14872 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226878.pdf [firstpage_image] =>[orig_patent_app_number] => 12716986 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/716986
Methods of inhibiting photoreceptor apoptosis Mar 2, 2010 Issued
Array ( [id] => 9020206 [patent_doc_number] => 08530191 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Method for preventing formation of trisulfide derivatives of polypeptides' [patent_app_type] => utility [patent_app_number] => 12/714900 [patent_app_country] => US [patent_app_date] => 2010-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4996 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12714900 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/714900
Method for preventing formation of trisulfide derivatives of polypeptides Feb 28, 2010 Issued
Menu